provid greater visibl
covid impact across
posit pre-announc organ sale
yoy lsd expect provid visibl
covid-rel demand/pantry-load tailwind
pre-announc indic bp covid-rel tailwind
organ sale growth provid updat guidanc busi impact
see covid-rel demand pick-up pre-announc result/ir
convers first indic around calendar result cpg
group offer key takeaway near-term group trend particularli food
expect yoy organ sale growth vs -lsd previous
bp ahead pre-covid estim key takeaway stood
us assum covid impact week averag global
quarter quarter foodservic sale mix
yoy total organ sale growth impli ex-
foodservic sale grew nearli yoy estim last three
quarter week assum organ sale yoy first non-
covid impact part quarter line pre-covid forecast
top-line acceler flow entir profit line due
increment cost product stress environ forecast
bp improv profit vs pre-covid forecast vs bp top-line
improv intern region also see covid-rel tailwind
develop market europ particularli uk less
emerg market consum lack much dispos incom stock
clearli demand strength quarter pantri load
rais balance-of-year boy organ sale growth forecast
assum greater food consumpt cocoon home
short-term covid relat social restrict well
extend macro weak similar feedback
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
compani coverag suppli chain gener held
stress period aid larg scale global resourc albeit
increment cost guidanc rais topline/ep forecast
price target see detail although remain ew reflect longer-
term concern remain top pick food space see note
reiter ow confid manag call
overview manag commentari issu press releas
market see provid new detail impact covid-
affect consum environ busi announc
postpon investor day earli may light covid
state expect see acceler total compani organ sale
growth report bp headwind come
divestitur fx impact despit signific declin foodservic
segment global sale due covid-rel demand although
expect full benefit top-line acceler flow ebitda
ep growth due increment cost associ volum ramp-up
rais pt ep estim rais organ sale growth
forecast line manag guidanc rais
ep higher organ sales/profit increas boy
forecast lesser extent higher ep forecast rais pt
previous
pt deriv dcf valuat revenue/ebitda compound-annual-growth-rate post
wacc tgr exit multipl impli base ebitda
packag food peer rang given bearish lt top-line outlook
expect easi comp covid
relat pantry-l tailwind support
organ sale analysi
us busi sale
highlight leverag low/no growth
end market weak competit
posit forecast organ
expans drive prot margin
unsustain level see margin
core sg wide gap peer
trade ev/ebitda low
k/gis/sjm/cag reect limit
growth outlook higher risk
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
view descript risk reward theme
bp top-line upsid us market share
gain int upsid drive
organ sale compound-annual-growth-rate bps/yr
margin expans top-line leverag
resumpt product save drive
wacc tgr exit multipl
strateg premium consolid halo
stabil follow
expect ebitda declin
model stabil start
yr ebitda compound-annual-growth-rate growth outsid north
america mostli off-set continu
weak us/canada dcf input
wacc tgr exit
bp top-line downsid
declin bps/yr price pressur xed
cost de-lever higher reinvest
drive ebitda compound-annual-growth-rate dcf
post wacc tgr
yoy chg ebitda
yoy chg adj ep
us top-line growth trend price gap privat
label categori growth
cut asset sale
relat impact pantry-load
china india
view explan region hierarchi
research highest favor quintil
favor us food industri volum trend
potenti upcom strateg review
horizon
us food volum trend health/wel
continu spend cut widen price gap
privat label commod pressur potenti
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
yoy chg sale
good sold
sale
yoy chg gp
sell gener adminstr expens
sg sale
yoy chg sg
oi sale
yoy chg oi
profit tax
yoy chg pbt
incom continu oper
incom attribut
yoy chg ni
incom attribut common
yoy chg adj ep
bridg gaap net incom
adjust reconcil net incom
depreci amort
defer compens stock compens
chang oper asset liabil effect
account payabl accru expens
net cash flow oper activ
flow invest activ
sale busi
purchas busi
net cash flow invest activ
flow financ activ
repurchas common share
issuanc common share
net cash flow financ activ
effect fx chang cash cash equival
cash equival begin year
net chang cash cash equival
cash equival end year
cash equival
s-t debt interest payabl
accumul comprehens incom loss
total liabil stockhold equiti
